Dynatronics Corporation (DYNT)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 7.63 Million USD | -24.78% |
| 2023 | 10.15 Million USD | -4.9% |
| 2022 | 10.67 Million USD | -17.17% |
| 2021 | 12.88 Million USD | -14.65% |
| 2020 | 15.09 Million USD | -21.26% |
| 2019 | 19.17 Million USD | -6.1% |
| 2018 | 20.42 Million USD | 77.44% |
| 2017 | 11.5 Million USD | 11.15% |
| 2016 | 10.35 Million USD | 14.16% |
| 2015 | 9.06 Million USD | -9.49% |
| 2014 | 10.02 Million USD | -9.62% |
| 2013 | 11.08 Million USD | -7.17% |
| 2012 | 11.94 Million USD | -4.34% |
| 2011 | 12.48 Million USD | -1.27% |
| 2010 | 12.64 Million USD | 1.89% |
| 2009 | 12.41 Million USD | 2.21% |
| 2008 | 12.14 Million USD | 75.67% |
| 2007 | 6.91 Million USD | -5.21% |
| 2006 | 7.29 Million USD | -12.14% |
| 2005 | 8.29 Million USD | 1.21% |
| 2004 | 8.2 Million USD | 32.54% |
| 2003 | 6.18 Million USD | -4.76% |
| 2002 | 6.49 Million USD | -7.79% |
| 2001 | 7.04 Million USD | 12.21% |
| 2000 | 6.27 Million USD | -9.0% |
| 1999 | 6.9 Million USD | 32.69% |
| 1998 | 5.2 Million USD | 13.04% |
| 1997 | 4.6 Million USD | 48.39% |
| 1996 | 3.1 Million USD | 10.71% |
| 1995 | 2.8 Million USD | 21.74% |
| 1994 | 2.3 Million USD | -20.69% |
| 1993 | 2.9 Million USD | -17.14% |
| 1992 | 3.5 Million USD | 16.67% |
| 1991 | 3 Million USD | -9.09% |
| 1990 | 3.3 Million USD | -17.5% |
| 1989 | 4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.3 Million USD | 86.42% |
| 2024 Q3 | 1.81 Million USD | -0.15% |
| 2024 Q4 | 1.69 Million USD | -6.89% |
| 2024 Q2 | 1.81 Million USD | -21.08% |
| 2023 Q1 | 3.64 Million USD | 39.18% |
| 2023 FY | 10.15 Million USD | -4.9% |
| 2023 Q2 | 3.06 Million USD | -15.94% |
| 2023 Q3 | 2.2 Million USD | -27.93% |
| 2023 Q4 | 1.23 Million USD | -43.95% |
| 2022 FY | 10.67 Million USD | -17.17% |
| 2022 Q1 | 3.66 Million USD | 56.73% |
| 2022 Q2 | 2.08 Million USD | -43.22% |
| 2022 Q3 | 2.31 Million USD | 11.08% |
| 2022 Q4 | 2.61 Million USD | 13.25% |
| 2021 FY | 12.88 Million USD | -14.65% |
| 2021 Q1 | 3.9 Million USD | 175.95% |
| 2021 Q2 | 3.34 Million USD | -14.38% |
| 2021 Q3 | 3.3 Million USD | -1.08% |
| 2021 Q4 | 2.33 Million USD | -29.26% |
| 2020 Q3 | 3.94 Million USD | -13.99% |
| 2020 Q1 | 5.15 Million USD | 13.47% |
| 2020 Q2 | 4.58 Million USD | -11.02% |
| 2020 FY | 15.09 Million USD | -21.26% |
| 2020 Q4 | 1.41 Million USD | -64.15% |
| 2019 Q3 | 4.4 Million USD | -5.87% |
| 2019 Q4 | 4.54 Million USD | 3.11% |
| 2019 FY | 19.17 Million USD | -6.1% |
| 2019 Q1 | 5.54 Million USD | 10.51% |
| 2019 Q2 | 4.67 Million USD | -15.64% |
| 2018 Q3 | 5.29 Million USD | -8.29% |
| 2018 Q4 | 5.01 Million USD | -5.14% |
| 2018 FY | 20.42 Million USD | 77.44% |
| 2018 Q1 | 4.33 Million USD | 47.66% |
| 2018 Q2 | 5.76 Million USD | 32.97% |
| 2017 FY | 11.5 Million USD | 11.15% |
| 2017 Q4 | 2.93 Million USD | 8.77% |
| 2017 Q3 | 2.7 Million USD | -12.09% |
| 2017 Q1 | 2.79 Million USD | 4.28% |
| 2017 Q2 | 3.07 Million USD | 9.97% |
| 2016 FY | 10.35 Million USD | 14.16% |
| 2016 Q4 | 2.67 Million USD | 7.78% |
| 2016 Q3 | 2.48 Million USD | -7.12% |
| 2016 Q2 | 2.67 Million USD | 6.62% |
| 2016 Q1 | 2.51 Million USD | 35.99% |
| 2015 Q3 | 2.19 Million USD | -11.03% |
| 2015 FY | 9.06 Million USD | -9.49% |
| 2015 Q1 | 2.56 Million USD | 2.47% |
| 2015 Q2 | 2.46 Million USD | -4.05% |
| 2015 Q4 | 1.84 Million USD | -15.76% |
| 2014 Q3 | 2.25 Million USD | -15.74% |
| 2014 FY | 10.02 Million USD | -9.62% |
| 2014 Q4 | 2.5 Million USD | 11.06% |
| 2014 Q1 | 2.58 Million USD | -2.86% |
| 2014 Q2 | 2.67 Million USD | 3.74% |
| 2013 FY | 11.08 Million USD | -7.17% |
| 2013 Q4 | 2.65 Million USD | 1.42% |
| 2013 Q3 | 2.61 Million USD | -15.46% |
| 2013 Q2 | 3.09 Million USD | 14.32% |
| 2013 Q1 | 2.71 Million USD | -5.98% |
| 2012 Q3 | 2.84 Million USD | -11.45% |
| 2012 Q4 | 2.88 Million USD | 1.34% |
| 2012 FY | 11.94 Million USD | -4.34% |
| 2012 Q1 | 3 Million USD | -4.37% |
| 2012 Q2 | 3.21 Million USD | 7.02% |
| 2011 Q1 | 2.95 Million USD | -2.37% |
| 2011 Q2 | 3.16 Million USD | 7.37% |
| 2011 Q4 | 3.13 Million USD | -2.64% |
| 2011 Q3 | 3.22 Million USD | 1.73% |
| 2011 FY | 12.48 Million USD | -1.27% |
| 2010 Q1 | 3.17 Million USD | 4.01% |
| 2010 Q3 | 3.11 Million USD | -6.37% |
| 2010 Q4 | 3.02 Million USD | -2.94% |
| 2010 Q2 | 3.32 Million USD | 4.66% |
| 2010 FY | 12.64 Million USD | 1.89% |
| 2009 Q3 | 2.84 Million USD | -14.16% |
| 2009 Q1 | 3.19 Million USD | 5.28% |
| 2009 Q2 | 3.31 Million USD | 3.69% |
| 2009 FY | 12.41 Million USD | 2.21% |
| 2009 Q4 | 3.05 Million USD | 7.47% |
| 2008 Q1 | 2.93 Million USD | 34.66% |
| 2008 Q2 | 3.33 Million USD | 13.88% |
| 2008 Q3 | 2.83 Million USD | -15.1% |
| 2008 Q4 | 3.03 Million USD | 7.07% |
| 2008 FY | 12.14 Million USD | 75.67% |
| 2007 FY | 6.91 Million USD | -5.21% |
| 2007 Q3 | 1.61 Million USD | -1.24% |
| 2007 Q1 | 1.49 Million USD | -18.93% |
| 2007 Q2 | 1.63 Million USD | 9.32% |
| 2007 Q4 | 2.17 Million USD | 35.18% |
| 2006 FY | 7.29 Million USD | -12.14% |
| 2006 Q4 | 1.84 Million USD | 1.99% |
| 2006 Q3 | 1.8 Million USD | -12.32% |
| 2006 Q2 | 2.05 Million USD | 29.56% |
| 2006 Q1 | 1.58 Million USD | -24.06% |
| 2005 Q4 | 2.09 Million USD | 3.71% |
| 2005 Q3 | 2.01 Million USD | -7.44% |
| 2005 FY | 8.29 Million USD | 1.21% |
| 2005 Q1 | 2.01 Million USD | -1.8% |
| 2005 Q2 | 2.17 Million USD | 8.33% |
| 2004 Q4 | 2.04 Million USD | -4.27% |
| 2004 Q2 | 2.08 Million USD | 8.13% |
| 2004 Q3 | 2.13 Million USD | 2.66% |
| 2004 FY | 8.2 Million USD | 32.54% |
| 2004 Q1 | 1.92 Million USD | 44.34% |
| 2003 FY | 6.18 Million USD | -4.76% |
| 2003 Q2 | 1.59 Million USD | -4.48% |
| 2003 Q1 | 1.66 Million USD | 7.53% |
| 2003 Q4 | 1.33 Million USD | -16.27% |
| 2003 Q3 | 1.59 Million USD | 0.26% |
| 2002 Q3 | 1.61 Million USD | 1.49% |
| 2002 FY | 6.49 Million USD | -7.79% |
| 2002 Q4 | 1.54 Million USD | -4.37% |
| 2002 Q2 | 1.59 Million USD | -7.85% |
| 2002 Q1 | 1.73 Million USD | -1.52% |
| 2001 Q2 | 1.68 Million USD | -0.78% |
| 2001 Q3 | 1.9 Million USD | 13.0% |
| 2001 Q4 | 1.75 Million USD | -7.63% |
| 2001 FY | 7.04 Million USD | 12.21% |
| 2001 Q1 | 1.69 Million USD | -14.37% |
| 2000 Q2 | 1.3 Million USD | -7.14% |
| 2000 Q3 | 1.61 Million USD | 24.51% |
| 2000 FY | 6.27 Million USD | -9.0% |
| 2000 Q1 | 1.4 Million USD | -6.67% |
| 2000 Q4 | 1.98 Million USD | 22.51% |
| 1999 Q2 | 1.7 Million USD | -22.73% |
| 1999 Q4 | 1.5 Million USD | 7.14% |
| 1999 FY | 6.9 Million USD | 32.69% |
| 1999 Q1 | 2.2 Million USD | 57.14% |
| 1999 Q3 | 1.4 Million USD | -17.65% |
| 1998 Q3 | 1.2 Million USD | -7.69% |
| 1998 FY | 5.2 Million USD | 13.04% |
| 1998 Q1 | 1.3 Million USD | 0.0% |
| 1998 Q2 | 1.3 Million USD | 0.0% |
| 1998 Q4 | 1.4 Million USD | 16.67% |
| 1997 Q4 | 1.3 Million USD | 8.33% |
| 1997 Q3 | 1.2 Million USD | 33.33% |
| 1997 Q1 | 1.1 Million USD | 83.33% |
| 1997 Q2 | 900 Thousand USD | -18.18% |
| 1997 FY | 4.6 Million USD | 48.39% |
| 1996 FY | 3.1 Million USD | 10.71% |
| 1996 Q4 | 600 Thousand USD | -14.29% |
| 1996 Q3 | 700 Thousand USD | -22.22% |
| 1996 Q2 | 900 Thousand USD | 50.0% |
| 1996 Q1 | 600 Thousand USD | 0.0% |
| 1995 FY | 2.8 Million USD | 21.74% |
| 1995 Q3 | 700 Thousand USD | -12.5% |
| 1995 Q2 | 800 Thousand USD | 0.0% |
| 1995 Q1 | 800 Thousand USD | 60.0% |
| 1995 Q4 | 600 Thousand USD | -14.29% |
| 1994 Q2 | 700 Thousand USD | 40.0% |
| 1994 Q1 | 500 Thousand USD | -37.5% |
| 1994 FY | 2.3 Million USD | -20.69% |
| 1994 Q4 | 500 Thousand USD | -28.57% |
| 1994 Q3 | 700 Thousand USD | 0.0% |
| 1993 Q4 | 800 Thousand USD | -11.11% |
| 1993 Q1 | 700 Thousand USD | -22.22% |
| 1993 FY | 2.9 Million USD | -17.14% |
| 1993 Q2 | 600 Thousand USD | -14.29% |
| 1993 Q3 | 900 Thousand USD | 50.0% |
| 1992 Q3 | 900 Thousand USD | 0.0% |
| 1992 Q2 | 900 Thousand USD | 12.5% |
| 1992 Q1 | 800 Thousand USD | 0.0% |
| 1992 Q4 | 900 Thousand USD | 0.0% |
| 1992 FY | 3.5 Million USD | 16.67% |
| 1991 Q2 | 700 Thousand USD | -12.5% |
| 1991 Q1 | 800 Thousand USD | -11.11% |
| 1991 Q4 | 800 Thousand USD | 0.0% |
| 1991 Q3 | 800 Thousand USD | 14.29% |
| 1991 FY | 3 Million USD | -9.09% |
| 1990 Q2 | 1.6 Million USD | 6.67% |
| 1990 Q4 | 900 Thousand USD | 0.0% |
| 1990 FY | 3.3 Million USD | -17.5% |
| 1990 Q1 | 1.5 Million USD | -25.0% |
| 1990 Q3 | 900 Thousand USD | -43.75% |
| 1989 Q1 | 1.5 Million USD | 0.0% |
| 1989 Q2 | 1.8 Million USD | 20.0% |
| 1989 FY | 4 Million USD | 0.0% |
| 1989 Q4 | 2 Million USD | -4.76% |
| 1989 Q3 | 2.1 Million USD | 16.67% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 343.385% |
| Cerus Corporation | 86.4 Million USD | 91.163% |
| OrthoPediatrics Corp. | 111.25 Million USD | 93.137% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -932.415% |
| Talis Biomedical Corporation | 371 Thousand USD | -1957.946% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 7.69% |
| Inogen, Inc. | 126.69 Million USD | 93.974% |
| Spectral AI, Inc. | 7.88 Million USD | 3.109% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 215.822% |
| CVRx, Inc. | 33.03 Million USD | 76.891% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -12416.357% |
| Orthofix Medical Inc. | 486.27 Million USD | 98.43% |
| Venus Concept Inc. | 52.16 Million USD | 85.364% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -199.411% |
| Bioventus Inc. | 328.19 Million USD | 97.674% |
| BrainsWay Ltd. | 23.09 Million USD | 66.935% |
| Envoy Medical, Inc. | -473 Thousand USD | 1714.16% |
| electroCore, Inc. | 13.22 Million USD | 42.273% |
| IceCure Medical Ltd | 1.3 Million USD | -487.306% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 226.198% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 16229.327% |
| MaxCyte, Inc. | 36.54 Million USD | 79.109% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -1572.441% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -8875.991% |
| PAVmed Inc | -3.96 Million USD | 292.414% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 239.197% |
| RxSight, Inc. | 53.76 Million USD | 85.799% |
| Sight Sciences, Inc. | 69.17 Million USD | 88.963% |
| SI-BONE, Inc. | 109.42 Million USD | 93.022% |
| TELA Bio, Inc. | 40.11 Million USD | 80.966% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 51.999% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 94.975% |
| LivaNova PLC | 771.25 Million USD | 99.01% |
| 908 Devices Inc. | 25.32 Million USD | 69.848% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 97.539% |
| Nemaura Medical Inc. | -1.47 Million USD | 617.138% |
| NeuroPace, Inc. | 48.12 Million USD | 84.134% |
| LENSAR, Inc. | 21.1 Million USD | 63.827% |
| Apyx Medical Corporation | 14.12 Million USD | 45.936% |
| Cutera, Inc. | 41.49 Million USD | 81.6% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 58.643% |
| BioSig Technologies, Inc. | 18 Thousand USD | -42316.544% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 92.594% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 43.918% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.141% |
| Axonics, Inc. | 274.55 Million USD | 97.219% |
| Outset Medical, Inc. | 29 Million USD | 73.672% |
| IRIDEX Corporation | 21.8 Million USD | 64.988% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 89.254% |
| IRadimed Corporation | 50.15 Million USD | 84.778% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -2560.271% |
| INVO Bioscience, Inc. | 1.08 Million USD | -602.947% |
| Telesis Bio, Inc. | 16.95 Million USD | 54.956% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 93.23% |
| Varex Imaging Corporation | 256.9 Million USD | 97.028% |
| Quipt Home Medical Corp. | 163.84 Million USD | 95.34% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1980.536% |
| Pulmonx Corporation | 50.75 Million USD | 84.956% |
| Modular Medical, Inc. | -768 Thousand USD | 1094.138% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -37.617% |
| Semler Scientific, Inc. | 61.2 Million USD | 87.525% |
| InMode Ltd. | 411.34 Million USD | 98.144% |
| Bruker Corporation | 1.51 Billion USD | 99.497% |
| Cytosorbents Corporation | 22.39 Million USD | 65.903% |
| DexCom, Inc. | 2.28 Billion USD | 99.666% |
| Align Technology, Inc. | 2.71 Billion USD | 99.719% |
| Viveve Medical, Inc. | 620 Thousand USD | -1131.448% |
| ZimVie Inc. | 290.38 Million USD | 97.371% |
| Movano Inc. | -158 Thousand USD | 4932.265% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 93.023% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -8875.991% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 97.924% |
| Profound Medical Corp. | 4.51 Million USD | -69.139% |
| Insulet Corporation | 1.15 Billion USD | 99.342% |
| enVVeno Medical Corporation | -546 Thousand USD | 1498.348% |
| Surmodics, Inc. | 93.05 Million USD | 91.795% |
| iCAD, Inc. | 14.53 Million USD | 47.475% |
| Nuwellis, Inc. | 4.98 Million USD | -53.221% |
| Biotricity, Inc. | 8.35 Million USD | 8.632% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 97.699% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 2226.397% |
| InspireMD, Inc. | 1.8 Million USD | -322.522% |
| PAVmed Inc. | -3.96 Million USD | 292.414% |
| BIOLASE, Inc. | 16.72 Million USD | 54.347% |
| Beyond Air, Inc. | -1.3 Million USD | 684.161% |
| FONAR Corporation | 45.14 Million USD | 83.086% |
| AxoGen, Inc. | 127.87 Million USD | 94.029% |
| Vivani Medical, Inc. | -357 Thousand USD | 2238.649% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 96.087% |
| Inari Medical, Inc. | 434.56 Million USD | 98.243% |
| UFP Technologies, Inc. | 112.22 Million USD | 93.197% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -60887.124% |
| Tenon Medical, Inc. | 1.24 Million USD | -515.228% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 9525.899% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -190.625% |
| AdaptHealth Corp. | 479.56 Million USD | 98.408% |
| Sintx Technologies, Inc. | 1.84 Million USD | -314.269% |
| NanoVibronix, Inc. | 1.53 Million USD | -396.745% |
| Quanterix Corporation | 70.64 Million USD | 89.193% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1980.536% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 45.697% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 85.534% |
| TransMedics Group, Inc. | 154.09 Million USD | 95.045% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -71.457% |
| NeuroMetrix, Inc. | 3.94 Million USD | -93.417% |
| Hyperfine, Inc. | 4.75 Million USD | -60.5% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 92.863% |
| Biomerica, Inc. | 611 Thousand USD | -1149.587% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 81.685% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 1077.646% |
| Silk Road Medical, Inc | 127.08 Million USD | 93.992% |